Analysts have recently evaluated Halozyme Therapeutics and provided 12-month price targets. The average target is $66.78, accompanied by a high estimate of $75.00 and a low estimate of $53.00. Holding ...

We recently compiled a list of the 9 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a look ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Advanced Micro Devices’ MI300X and AI strategy challenge Nvidia’s monopoly. Learn why AMD stock is a buy with rising demand for AI and chip advancements.

By portfolio, net revenue from Hasbro’s ( HAS) franchise brands like Dungeons and Dragons, fell 7%, and declined 11% for its portfolio brands (Monopoly, PLAY DOH, Nerf, etc), all of which was ...

Lam Research was upgraded to Positive from Neutral by the analysts at Susquehanna following its Investor Day in New York City on Wednesday.

Cocks announced an increased cost-saving target of $1 billion by 2027, up from $750 million, with 50% expected to impact the bottom line. CFO Gina Goetter mentioned delivering $227 million in net cost ...

The Nvidia GeForce RTX 5070 Ti packs great 4K performance not too far off the RTX 5080, but custom options like the Gigabyte ...

L3Harris Technologies posted solid 2024 results, despite a 25% drop in shares. Learn why LHX stock remains a strong buy with ...

Wells Fargo analyst Mohit Bansal raised the firm’s price target on Halozyme (HALO) to $60 from $57 and keeps an Equal Weight rating on the ...

Full Year 2024 Results Key Financial Results Revenue: US$1.02b (up 22% from ...